421 related articles for article (PubMed ID: 33662455)
21. Hierarchical Responsive Nanoplatform with Two-Photon Aggregation-Induced Emission Imaging for Efficient Cancer Theranostics.
Ma B; Zhuang W; Xu H; Li G; Wang Y
ACS Appl Mater Interfaces; 2019 Dec; 11(50):47259-47269. PubMed ID: 31769279
[TBL] [Abstract][Full Text] [Related]
22. A cancer-specific activatable theranostic nanodrug for enhanced therapeutic efficacy via amplification of oxidative stress.
Yu XA; Lu M; Luo Y; Hu Y; Zhang Y; Xu Z; Gong S; Wu Y; Ma XN; Yu BY; Tian J
Theranostics; 2020; 10(1):371-383. PubMed ID: 31903126
[No Abstract] [Full Text] [Related]
23. Smart Nanoplatforms Responding to the Tumor Microenvironment for Precise Drug Delivery in Cancer Therapy.
Wang Y; Deng T; Liu X; Fang X; Mo Y; Xie N; Nie G; Zhang B; Fan X
Int J Nanomedicine; 2024; 19():6253-6277. PubMed ID: 38911497
[TBL] [Abstract][Full Text] [Related]
24. Redox-responsive theranostic nanoplatforms based on inorganic nanomaterials.
Han L; Zhang XY; Wang YL; Li X; Yang XH; Huang M; Hu K; Li LH; Wei Y
J Control Release; 2017 Aug; 259():40-52. PubMed ID: 28288893
[TBL] [Abstract][Full Text] [Related]
25. A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis.
Luo S; Ma D; Wei R; Yao W; Pang X; Wang Y; Xu X; Wei X; Guo Y; Jiang X; Yuan Y; Yang R
Acta Biomater; 2022 Jan; 138():518-527. PubMed ID: 34775124
[TBL] [Abstract][Full Text] [Related]
26. Smart Cancer Cell Targeting Imaging and Drug Delivery System by Systematically Engineering Periodic Mesoporous Organosilica Nanoparticles.
Lu N; Tian Y; Tian W; Huang P; Liu Y; Tang Y; Wang C; Wang S; Su Y; Zhang Y; Pan J; Teng Z; Lu G
ACS Appl Mater Interfaces; 2016 Feb; 8(5):2985-93. PubMed ID: 26767305
[TBL] [Abstract][Full Text] [Related]
27. Functionalization of Metal and Carbon Nanoparticles with Potential in Cancer Theranostics.
Mauro N; Utzeri MA; Varvarà P; Cavallaro G
Molecules; 2021 May; 26(11):. PubMed ID: 34064173
[TBL] [Abstract][Full Text] [Related]
28. A continuous stimuli-responsive system for NIR-II fluorescence/photoacoustic imaging guided photothermal/gas synergistic therapy.
Zheng Z; Chen Q; Dai R; Jia Z; Yang C; Peng X; Zhang R
Nanoscale; 2020 Jun; 12(21):11562-11572. PubMed ID: 32432283
[TBL] [Abstract][Full Text] [Related]
29. Redox-Activatable Theranostic Co-Prodrug for Precise Tumor Diagnosis and Selective Combination Chemotherapy.
Qian J; Xu Z; Meng C; Liu Y; Wu H; Wang Y; Yang J; Zheng H; Ran F; Liu GQ; Ling Y
J Med Chem; 2022 Aug; 65(15):10393-10407. PubMed ID: 35877176
[TBL] [Abstract][Full Text] [Related]
30. Amino acids and doxorubicin as building blocks for metal ion-driven self-assembly of biodegradable polyprodrugs for tumor theranostics.
Wang D; Zhang N; Yang T; Zhang Y; Jing X; Zhou Y; Long J; Meng L
Acta Biomater; 2022 Jul; 147():245-257. PubMed ID: 35487428
[TBL] [Abstract][Full Text] [Related]
31. All-in-One Theranostic Nanomedicine with Ultrabright Second Near-Infrared Emission for Tumor-Modulated Bioimaging and Chemodynamic/Photodynamic Therapy.
Xu J; Shi R; Chen G; Dong S; Yang P; Zhang Z; Niu N; Gai S; He F; Fu Y; Lin J
ACS Nano; 2020 Aug; 14(8):9613-9625. PubMed ID: 32806021
[TBL] [Abstract][Full Text] [Related]
32. Stimuli-activatable nanomedicine meets cancer theranostics.
Li H; Feng Y; Luo Q; Li Z; Li X; Gan H; Gu Z; Gong Q; Luo K
Theranostics; 2023; 13(15):5386-5417. PubMed ID: 37908735
[TBL] [Abstract][Full Text] [Related]
33. Cu-MOF chemodynamic nanoplatform via modulating glutathione and H
Tian H; Zhang M; Jin G; Jiang Y; Luan Y
J Colloid Interface Sci; 2021 Apr; 587():358-366. PubMed ID: 33360905
[TBL] [Abstract][Full Text] [Related]
34. Rational Design of a Triple Tumor Microenvironment-Responsive Nanoplatform for Enhanced Tumor Theranostics.
Zhang S; Han X; Chen X; Liu Y; Zhou J
Chemistry; 2023 Feb; 29(7):e202202469. PubMed ID: 36219493
[TBL] [Abstract][Full Text] [Related]
35. Tumor Microenvironment-Specific Functional Nanomaterials for Biomedical Applications.
Zhao L; Liu H; Xing Y; Wang R; Cheng Z; Lv C; Lv Z; Yu F
J Biomed Nanotechnol; 2020 Sep; 16(9):1325-1358. PubMed ID: 33419489
[TBL] [Abstract][Full Text] [Related]
36. Recent development of pH-responsive theranostic nanoplatforms for magnetic resonance imaging-guided cancer therapy.
Li X; Yue R; Guan G; Zhang C; Zhou Y; Song G
Exploration (Beijing); 2023 Jun; 3(3):20220002. PubMed ID: 37933379
[TBL] [Abstract][Full Text] [Related]
37. Integrated Nanoparticles To Synergistically Elevate Tumor Oxidative Stress and Suppress Antioxidative Capability for Amplified Oxidation Therapy.
Yin W; Li J; Ke W; Zha Z; Ge Z
ACS Appl Mater Interfaces; 2017 Sep; 9(35):29538-29546. PubMed ID: 28799751
[TBL] [Abstract][Full Text] [Related]
38. All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.
Cai Y; Chen X; Si J; Mou X; Dong X
Small; 2021 Dec; 17(52):e2103072. PubMed ID: 34561968
[TBL] [Abstract][Full Text] [Related]
39. Recent Advances in Metal-Phenolic Networks for Cancer Theranostics.
Zhang Z; Xie L; Ju Y; Dai Y
Small; 2021 Oct; 17(43):e2100314. PubMed ID: 34018690
[TBL] [Abstract][Full Text] [Related]
40. Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.
Chen Z; Krishnamachary B; Pachecho-Torres J; Penet MF; Bhujwalla ZM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1595. PubMed ID: 31642207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
